HIGHLIGHTS
- who: Ms Farheen et al. from the School of Pharmaceutical and Population Health Informatics (SoPPHI), DIT University, Dehradun, India have published the paper: Harnessing Folate-Functionalized Nasal Delivery of Dox-Erlo-Loaded Biopolymeric Nanoparticles in Cancer Treatment: Development, Optimization, Characterization, and Biodistribution Analysis, in the Journal: Pharmaceuticals 2023, 207 of 10/09/2021
- what: The aim of this study is to develop Doxorubicin-Erlotinib nanoparticles (Dox-Erlo NPs) and folate-armored Dox-Erlo-NP conjugates for targeting glioma cancer. The authors demonstrate that the NP conjugates studied in this paper may ameliorate the BBB penetration . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.